Animal models in uveal melanoma: Establishment and research

Canadian Journal of Ophthalmology

Volumn 39, Issue 4, 2004, Pages 433-440

  Morilla Grasa, Antonio ^a  

^a UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

Animal models; Metastasis; Research; Uveal melanoma

Indexed keywords

CYCLOSPORIN; DACARBAZINE; EFLORNITHINE; IMMUNOSUPPRESSIVE AGENT; PRINOMASTAT;

ANIMAL MODEL; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; EXPERIMENTAL MODEL; GENE THERAPY; HISTOGENESIS; HUMAN; LIFE EXPECTANCY; MEDICAL RESEARCH; METASTASIS; NONHUMAN; ONCOVIRINAE; PROGNOSIS; QUALITY OF LIFE; REVIEW; TRANSGENIC MOUSE; UVEA MELANOMA;

EID: 3042777265     PISSN: 00084182     EISSN: 17153360     Source Type: Journal    
DOI: 10.1016/S0008-4182(04)80016-4     Document Type: Article

References (39)

1. Zimmerman LE, McLean IW, Foster WD. Does enucleation of the eye containing a malignant melanoma prevent or accelerate the dissemination of tumour cells? Br J Ophthalmol 1978;62:420-5.
2. Zimmerman LE, McLean IW, Foster WD. Statistical analysis of follow-up data concerning uveal melanomas, and influence of enucleation. Ophthalmology 1980;87: 557-64.
3. Gamel JW, McLean IW, Greenberg RA, Naids RM, Folberg R, Donoso HA, et al. Objective assessment of the malignant potential of intraocular melanomas with standard microslides stained with hematoxylin-eosin. Hum Pathol 1985;16:689-92.
4. Albert DM. Needs for animal models of human diseases of the eye. Induced animal models of human ocular disease with particular consideration of ocular melanoma. Am J Pathol 1980;101:S177-85.
5. Albert DM, Shadduck JA, Liu HS, Sunderman FW Jr, Wagoner MD, Dohlman HG, et al. Animal models for the study of uveal melanoma. Int Ophthalmol Clin 1980; 20:143-60.
6. Dubielzig RR. Ocular neoplasia in small animals. Vet Clin North Am Small Anim Pract 1990;20:837-48.
7. Grossniklaus HE, Dithmar S, Albert DM. Animal models of uveal melanoma. Melanoma Res 2000;10:195-211.
8. Pe'er J, Folberg R, Massicotte SJ, Baron J, Parys-Van Ginderdeuren R, Zimmerman B, et al. Clinicopathologic spectrum of primary uveal melanocytic lesions in an animal model. Ophthalmology 1992;99:977-86.
9. Dithmar S, Rusciano D, Lynn MJ, Lawson DH, Armstrong CA, Grossniklaus HE. Neoadjuvant interferon alfa-2b treatment in a murine model for metastatic ocular melanoma: a preliminary study. Arch Ophthalmol 2000; 118:1085-9.
10. Kramer TR, Powell MB, Wilson MM, Salvatore J, Grossniklaus HE. Pigmented uveal tumours in a transgenic mouse model. Br J Ophthalmol 1998;82:953-60.
11. Syed NA, Windle JJ, Darjatmoko SR, Lokken JM, Steeves RA, Chappell R, et al. Transgenic mice with pigmented intraocular tumours: tissue of origin and treatment. Invest Ophthalmol Vis Sci 1998;39:2800-5.
12. Gragoudas ES, Egan KM. Uveal melanoma: a rare malignancy. Ophthalmology 2000;107:1441-2.
13. Ma D, Alizadeh H, Comerford SA, Gething MJ, Sambrook JF, Anand R, et al. Rejection of intraocular tumours from transgenic mice by tumour-infiltrating lymphocytes. Curr Eye Res 1994;13:361-9.
14. Albert DM, Wagoner MD, Moazed K, Kimball GP, Gonder JR. Heterotransplantation of human choroidal melanoma into the athymic "nude" mouse. Invest Ophthalmol Vis Sci 1980;19:555-9.
15. Stahelin H. Cyclosporine A. Historical background. Prog Allergy 1986;38:19-27.
16. Matsuda S, Koyasu S. Mechanisms of action of cyclosporine. Immunopharmacology 2000;47:119-25.
17. Yang CP, Shittu E, Bell EB. Specific B cell tolerance is induced by cyclosporine A plus donor-specific blood transfusion pre-treatment: prolonged survival of MHC class I disparate cardiac allografts. J Immunol 2000;164: 2427-32.
18. Yu XZ, Carpenter P, Arnasetti C. Advances in transplantation tolerance. Lancet 2001;357:1959-63.
19. Green CJ. Experimental transplantation. Prog Allergy 1986;38:123-58.
20. Blanco G, Saornil MA, Domingo E, Diebold Y, López R, Rábano G, et al. Uveal melanoma model with metastasis in rabbits: effects of different doses of cyclosporine A. Curr Eye Res 2000;21:740-7.
21. López R, Saornil MA, Rábano G, Blanco G, Morilla A, Ordóñez JL, et al. Development of experimental choroidal tumours from different melanocytic cell lines in albino rabbits [abstract]. Invest Ophthalmol Vis Sci 1998;39:S284.
22. Ordóñez JL, Saornil MA, Domingo E, Blanco G, Diebold Y, Morilla-Grasa A, et al. The need for continuous immunosuppression with cyclosporine A to maintain an experimental model of uveal melanoma. Melanoma Res 2002; 12:1-7.
23. Hu LK, Huh K, Gragoudas ES, Young LHY. Establishment of pigmented choroidal melanomas in a rabbit model. Retina 1994;14:264-9.
24. Liu LH, Ni C. Rabbit model of uveal Greene melanoma: morphologic studies of metastatic lesions. Graefes Arch Clin Exp Ophthalmol 1983;220:179-83.
25. Gratwohl A, Riederer I, Graf E, Speck B. Cyclosporine toxicity in rabbits. Lab Anim 1986;20:213-20.
26. Hewitt CW, Black KS, Gratwohl A, Gonzalez GA, Leach TA, Furnas DW, et al. Lethal cyclosporine associated toxicity in the rabbit: similar findings in two distant and independent transplant laboratories. J Clin Lab Immunol 1990;31:23-5.
27. Mueller AJ, Folberg R, Freeman WR, Bartsch DU, Bergeron-Lynn G, Mehaffey MG, et al. Evaluation of the human choroidal melanoma rabbit model for studying microcirculation patterns with confocal ICG and histology. Exp Eye Res 1999;68:671-8.
28. Mueller AJ, Maniotis AJ, Freeman WR, Bartsch DU, Schaller UC, Bergeron-Lynn G, et al. An orthopic model for human uveal melanoma in SCID mice. Microvasc Res 2002;64:207-13.
29. Morilla-Grasa A, Caissie AL, López R, Fernandez N, Rábano G, Ordóñez JL, et al. Animal model of primary and metastatic human uveal melanoma: co-expression of vimentin and cytokeratin by melanoma cells with different metastatic potential [abstract]. Invest Ophthalmol Vis Sci 2001;42:S217.
30. Ma D, Niederkorn JY. Role of epidermal growth factor receptor in the metastasis of intraocular melanomas. Invest Ophthalmol Vis Sci 1998;39:1067-75.
31. Niederkorn JY, Mellon J, Pidherney M, Mayhew E, Anand R. Effect of anti-ganglioside antibodies on the metastatic spread of intraocular melanomas in a nude mouse model of human uveal melanoma. Curr Eye Res 1993;12:347-58.
32. Ma D, Luyten GP, Luider TM, Niederkorn JY. Relationship between natural killer cell susceptibility and metastasis of human uveal melanoma cells in a murine model. Invest Ophthalmol Vis Sci 1995;36:435-41.
33. Ma D, Luyten GP, Luider TM, Jager MJ, Niederkorn JY. Association between NM23-H1 gene expression and metastasis of human uveal melanoma in an animal model. Invest Ophthalmol Vis Sci 1996;37:2293-301.
34. Ma D, Gerard RD, Li XY, Alizadeh H, Niederkorn JY. Inhibition of metastasis of intraocular melanomas by adenovirus-mediated gene transfer of plasminogen activator type 1 (PAI-1) in an athymic mouse model. Blood 1997; 90:2738-46.
35. Ordóñez JL, Saornil MA, Galarreta D, Blanco G, Fernández N, Sánchez C, et al. Systemic therapy with adenovirus d1118 in an experimental uveal melanoma [abstract]. Invest Ophthalmol Vis Sci 2001;42:S219.
36. Fournier GA, Saulenas AM, Seddon JM, Goitein M, Albert DM, Polivogianis L, et al. The effects of pre-enucleation irradiation on the development of metastases from intraocular Greene melanoma in hamsters. Am J Ophthalmol 1985;100:669-77.
37. Sanborn G, Niederkorn J, Kan-Mitchell J, Albert D. Prevention of metastasis of intraocular melanoma in mice treated with difluoromethylomithine. Graefes Arch Clin Exp Ophthalmol 1992;230:72-7.
38. Sanborn GE, Niederkorn JY, Gamel JW. Efficacy of dacarbazine (DTIC) in preventing metastases arising from intraocular melanomas in mice. Graefes Arch Clin Exp Ophthalmol 1992;230:192-6.
39. Ozerdem U, Mach-Hofacre B, Varki N, Folberg R, Mueller AJ, Ochabski R, et al. The effect of prinomastat (AG3340), a synthetic inhibitor of matrix metalloproteinases, on uveal melanoma rabbit model. Curr Eye Res 2002;24:86-91.